top of page
Home
Our Science
Astatine-211 Targeted Alpha Therapies
FLEX-NK Bifunctional Antibodies
Our Team
News & Resources
Media
Contact Us
Management Team
Chief Executive Officer
Daniel Teper,
PharmD, MBA
Chief Medical Officer
Jason D. Hurt,
MD, MBA
Chief Financial Officer
​
Shai Lankry,
MBA
Chief Communications Officer
Lyn Falconio
Corporate Secretary
​
Gilles Seydoux,
PharmD
President, NAYA Europe
Jean-Marc Menat,
MD
Chief Pharmaceutical Officer,
Head of Supply Chain
Nicolas Cherrier,
PharmD
Chief of Staff
Hortense Desbarrieres,
PharmD
Board of Directors
Ely Benaim,
MD
Margarita Chavez,
JD
Anne Lauvergeon,
PhD
Rahul Singhvi,
PhD, MBA
Daniel Teper,
PharmD, MBA
bottom of page